Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a stroke (either a bleeding stroke or a blocked-blood-vessel stroke)
- People for whom at least 3 months have passed since their stroke occurred
- People who developed a language and communication difficulty (aphasia) as a result of their stroke
- People whose aphasia falls within a specific severity range, as measured by a standardised Korean language assessment test (confirm with trial site for exact score details)
- People aged 19 years or older
- People whose first and native language is Korean
- People who are able to use the study device or complete a workbook-based training program without significant difficulty
- People who are willing to take part voluntarily and sign a written consent form
Who may not be able to join:
- People whose language difficulties were caused by something other than a stroke, such as a head injury, brain tumour, or a degenerative brain condition
- People who have a history of language difficulties related to a developmental disorder
- People who are currently receiving speech or language therapy, or who are already taking part in another clinical trial involving language treatment
- People who are currently taking medication for a serious psychiatric condition, such as bipolar disorder, major depression, schizophrenia, or alcohol or substance dependence
- People who are unable to read or write
- People who have severe cognitive difficulties (such as serious memory or thinking problems) that would make it hard to understand or take part in the study activities
- People considered unsuitable for participation by the doctor or investigator running the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sung Il Sohn, MD, PhD, Keimyung University Dongsan Medical Center
Phone: +82-2-488-6542
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in K-WAB or PK-WAB-R Aphasia Quotient (AQ) Score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.